TF and acute lymphoblastic leukemia: To determine whether these upregulated TFs promote unique chromatin-accessibility landscapes among B-ALL subtypes, we also performed TF footprinting on subtype-enriched DASs by comparing differential footprint scores between each B-ALL subtype group and non-subtype patient sample group (Figures 5C and S11).